Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$865K Buy
28,840
+10,442
+57% +$331K 0.01% 876
2025
Q4
$538K Buy
18,398
+874
+5% +$23.1K ﹤0.01% 1060
2025
Q3
$458K Sell
17,524
-153
-0.9% -$3.79K ﹤0.01% 1226
2025
Q2
$398K Buy
+17,677
New +$363K ﹤0.01% 1167
2025
Q1
Sell
-17,300
Closed -$368K 1361
2024
Q4
$368K Buy
17,300
+4,055
+31% +$88.9K ﹤0.01% 1198
2024
Q3
$307K Sell
13,245
-2,220
-14% -$52.2K ﹤0.01% 1171
2024
Q2
$344K Buy
15,465
+1,290
+9% +$27.5K ﹤0.01% 1134
2024
Q1
$312K Buy
14,175
+385
+3% +$7.83K ﹤0.01% 1160
2023
Q4
$258K Buy
13,790
+750
+6% +$13.6K ﹤0.01% 1184
2023
Q3
$245K Buy
+13,040
New +$244K ﹤0.01% 1141

Other funds holding IX

Park Avenue Securities's IX Position: Q1 2026 in Review

Park Avenue Securities increased its ORIX (IX) stake by 57% in Q1 2026, buying an estimated $331K and bringing the position to 28,840 shares worth $865K. The position accounts for 0.01% of the portfolio, ranked #876.

Park Avenue Securities first reported a position in IX in Q3 2023 and has held it in 10 quarters since. 280 funds tracked by Wall St. Rank hold IX as of Q1 2026.

  • Park Avenue Securities held 28,840 shares of ORIX worth $865K as of Q1 2026.
  • Park Avenue Securities bought 10,442 ORIX shares in Q1 2026, an estimated $331K.
  • ORIX made up 0.01% of Park Avenue Securities's portfolio in Q1 2026, its #876 holding.
  • Park Avenue Securities first reported a position in ORIX in Q3 2023 and has held it in 10 quarters since.
  • 280 funds tracked by Wall St. Rank held ORIX as of Q1 2026.

Based on Park Avenue Securities's 13F filing for Q1 2026, filed 7 Apr 2026.